X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-renewal-of-exclusive-distribution-agreement-for-evomela-in-china-301495624.html
https://www.fiercebiotech.com/research/a-new-target-multiple-myeloma-tak1-blocker-boosts-chemo-s-cancer-killing-power-preclinical
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-september-2020
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-launch-of-evomela-melphalan-for-injection-in-china-300899773.html
https://endpts.com/takeda-suffers-another-setback-in-its-quest-to-expand-myeloma-drugs-reach-and-blockbuster-potential/
https://www.pharmaceutical-technology.com/news/deals-and-mas-this-week-alnylam-pharmaceuticals-novartis/
https://medcitynews.com/2019/01/spectrum-pharmaceuticals-sells-marketed-drugs-to-aurobindo-subsidiary-for-up-to-300m/?rf=1
http://www.pharmatimes.com/news/janssen_bags_new_eu_approval_for_darzalex_1251100
http://www.pmlive.com/pharma_news/safety_scuppers_combo_trials_with_j_and_jgenmabs_darzalex_1237341
https://www.fiercebiotech.com/biotech/j-j-preps-for-esketamine-filing-resistant-depression-despite-a-missed-trial
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-provides-update-on-evomela-300624953.html
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-50-million-private-placement-to-prepare-company-for-commercialization-in-china-300616697.html
http://www.business-standard.com/article/companies/dr-reddy-s-rolls-out-generic-melphalan-hydrochloride-cancer-injection-in-us-117122600480_1.html
http://www.pharmatimes.com/news/j_and_js_darzalex_shows_promise_in_newly-diagnosed_multiple_myeloma_1214308
https://www.fiercepharma.com/pharma/johnson-johnson-scores-big-darzalex-win-first-line-myeloma-slashing-risks-half
https://www.bloomberg.com/news/articles/2017-01-30/old-cancer-drug-gets-1-000-plus-price-hike-in-frugal-u-k
http://www.prnewswire.com/news-releases/casi-pharmaceuticals-import-drug-registration-application-for-evomela-accepted-for-review-by-cfda-300372264.html
http://www.pharmatimes.com/news/nice_rejects_earlier_use_of_multiple_myeloma_drugs_1176577
http://www.pmlive.com/pharma_news/italian_pharma_scandals_prompts_call_for_eu-wide_pricing_probe_1168682
https://www.pharmacompass.com/pdf/news/par-sterile-products-anda-melphalan-hydrochloride-approved-in-us-1472293110.pdf
https://www.pharmacompass.com/pdf/news/spectrum-pharms-evomelamelphalan-approved-in-us-as-a-chemotherapy-drug-1457776915.pdf
http://www.prnewswire.com/news-releases/delcath-announces-initiation-of-phase-3-trial-of-melphalanhds-system-for-treatment-of-hepatic-dominant-ocular-melanoma-300206853.html
http://www.nasdaq.com/article/alvogen-to-buy-product-portfolio-from-pfizer-for-us-market-20150826-00482?
http://www.4-traders.com/LIGAND-PHARMACEUTICALS-IN-17306/news/Ligand-Pharmaceuticals--Partner-Spectrum-Pharmaceuticals-Announces-Submission-of-New-Drug-Applicati-19596827/
Market Place
Share 
